74 related articles for article (PubMed ID: 34918856)
21. Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.
Hcini N; Maamri F; Picone O; Carod JF; Lambert V; Mathieu M; Carles G; Pomar L
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():11-18. PubMed ID: 33310656
[TBL] [Abstract][Full Text] [Related]
22. [
Cabrera Villegas A; Romero Robles LG; Boulvard Chollet XLE; Albornoz Almada MC; Mangas Losada M; Garrastachu P; Cañete Sánchez FM; Ramírez Lasanta R; Delgado Bolton RC
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):786-793. PubMed ID: 32936372
[TBL] [Abstract][Full Text] [Related]
23. Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
Papayanni PG; Chasiotis D; Koukoulias K; Georgakopoulou A; Iatrou A; Gavriilaki E; Giannaki C; Bitzani M; Geka E; Tasioudis P; Chloros D; Fylaktou A; Kioumis I; Triantafyllidou M; Dimou-Besikli S; Karavalakis G; Boutou AK; Siotou E; Anagnostopoulos A; Papadopoulou A; Yannaki E
Clin Infect Dis; 2021 Dec; 73(11):2073-2082. PubMed ID: 33905481
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic SARS-CoV-2 Infection in Children.
Cai J; Wang X; Zhao J; Ge Y; Xu J; Tian H; Chang H; Xia A; Wang J; Zhang J; Wei Z; Li J; Wang C; Wang J; Zhu Q; Zhai X; Zeng M
Virol Sin; 2020 Dec; 35(6):803-810. PubMed ID: 33146873
[TBL] [Abstract][Full Text] [Related]
25. [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].
Tanaka H; Ogata T; Morisada K; Tanaka S; Yoshida T; Nakanishi H; Misawa A; Nishida T; Tetsu O; Nagata M; Nakazato E
Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):550-558. PubMed ID: 33994491
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Zambelli A; Chiudinelli L; Fotia V; Negrini G; Bosetti T; Callegaro A; Di Croce A; Caremoli ER; Moro C; Milesi L; Poletti P; Tasca C; Mandalà M; Merelli B; Mosconi S; Arnoldi E; Bettini A; Bonomi L; Messina C; Ghilardi L; Chirco A; Maracino M; Tondini C
Oncologist; 2021 Apr; 26(4):341-347. PubMed ID: 33355953
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the validity of Ag PANBIO-COVID19 in the diagnosis of SARS-CoV-2 infection in asymptomatic or mildly infected patients].
Gras-Valenti P; Vidal I; Montiel-Higuero I; Escribano I; Algado-Selles N; Chico-Sánchez P; Ventero MP; Jiménez-Sepulveda N; Molina-Pardines C; Merino-Lucas E; Sánchez-Payá J; Rodríguez JC
Rev Esp Quimioter; 2021 Dec; 34(6):618-622. PubMed ID: 34549577
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic COVID-19 Patients Can Contaminate Their Surroundings: an Environment Sampling Study.
Wei L; Lin J; Duan X; Huang W; Lu X; Zhou J; Zong Z
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581071
[TBL] [Abstract][Full Text] [Related]
29. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland.
Kuchar E; Załęski A; Wronowski M; Krankowska D; Podsiadły E; Brodaczewska K; Lewicka A; Lewicki S; Kieda C; Horban A; Kloc M; Kubiak JZ
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):541-547. PubMed ID: 32986153
[TBL] [Abstract][Full Text] [Related]
30. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
[TBL] [Abstract][Full Text] [Related]
31. Negative SARS-CoV-2 PCR or rapid antigen test result and the subsequent risk of being infectious: a mathematical simulation study.
Krumkamp R; Kreuels B; Jaeger VK; May J; Mikolajczyk R; Karch A
BMC Med Res Methodol; 2021 Aug; 21(1):165. PubMed ID: 34376152
[TBL] [Abstract][Full Text] [Related]
32. Surveillance testing reveals a significant proportion of hospitalized patients with SARS-CoV-2 are asymptomatic.
Arnold FW; Bishop S; Oppy L; Scott L; Stevenson G
Am J Infect Control; 2021 Mar; 49(3):281-285. PubMed ID: 33428982
[TBL] [Abstract][Full Text] [Related]
33. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.
Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V
J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and management of asymptomatic SARS-CoV-2 infections.
Tanriover MD; Fathi A; Raspe M; Novais AG; Uyaroğlu OA
J Basic Clin Physiol Pharmacol; 2021 Sep; 33(1):1-7. PubMed ID: 34517438
[TBL] [Abstract][Full Text] [Related]
35. A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay.
Khoshchehreh M; Wald-Dickler N; Holtom P; Butler-Wu SM
J Clin Virol; 2020 Dec; 133():104683. PubMed ID: 33142250
[TBL] [Abstract][Full Text] [Related]
36. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
[TBL] [Abstract][Full Text] [Related]
37. Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March-June 2020: Epidemiological Implications.
Cruz-Rodríguez E; Baldoquín-Rodríguez W; Molina-Águila N; Galindo-Santana BM; Romero-Placeres M; González-Gross TM; Morgado-Vega I; Olivera-Nodarse Y; Guadalupe-Guzmán M
MEDICC Rev; 2022 Jan; 24(1):21-27. PubMed ID: 35157635
[TBL] [Abstract][Full Text] [Related]
38. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
39. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
[TBL] [Abstract][Full Text] [Related]
40. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era.
Arpino G; De Angelis C; De Placido P; Pietroluongo E; Formisano L; Bianco R; Fiore G; Montella E; Forestieri V; Lauria R; Cardalesi C; Vozzella EA; Iervolino A; Giuliano M; De Placido S
ESMO Open; 2020 Sep; 5(5):e000885. PubMed ID: 32958531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
